World Inflammatory Bowel Disease Day Publicity Campaign Launched in Beijing

    

   On the eve of the World Inflammatory Bowel Disease Day on May 19, the Inflammatory Bowel Disease Group of the Digestive Disease Branch of the Chinese Medical Association and Xian Janssen Pharmaceutical Ltd. common Started "Love" in 2015 · Always here, you are not alone "World Inflammatory Bowel Disease Day publicity campaign.". The project aims to arouse the society's attention to inflammatory bowel disease, a chronic and disabling disease, improve the public's awareness of inflammatory bowel disease, and emphasize the importance of scientific treatment and scientific improvement of patients' condition and quality of life.

   Inflammatory bowel disease (IBD) mainly includes Crohn's disease (CD) and ulcerative nodules enteritis (UC)。 Crohn's disease can affect all parts of the digestive tract from the mouth to the anus. The lesion can affect the whole layer of the intestine, and the diseased intestine and the normal healthy intestine can alternate. Ulcerative colitis However, the influence of intestinal cancer is often limited to the colon (large intestine), and there is no normal intestinal tissue between the diseased intestinal segments.

   According to statistics, from January 1991 to December 2010, the total number of cases of inflammatory bowel disease reported in China in the past 20 years was 342924. Compared with the previous 10 years, the total number of cases in the latter 10 years increased by more than 2.4 times, of which Ulcerative colitis It has increased by more than 2.3 times, and Crohn's disease has even increased by more than 15 times. [1] Professor Qian Jiaming, head of the Inflammatory Bowel Disease Group of the Digestive Branch of the Chinese Medical Association and director of the Department of Gastroenterology of Peking Union Medical College Hospital, stressed that "the number of cases of inflammatory bowel disease has increased year by year in the past 10 years, especially Crohn's disease. We should actively promote more gastroenterologists across the country to deeply understand inflammatory bowel disease and give full attention to it. At the same time, the public should also have some awareness of it, so as to facilitate the early diagnosis and formal treatment of the disease, and ultimately help reduce the disease burden of patients and improve the quality of life. "

   Professor Hu Pinjin, chairman of the Asian Inflammatory Bowel Disease and Colitis Organization and director of the Department of Gastroenterology of the Sixth Affiliated Hospital of Sun Yat sen University, said, "Inflammatory Bowel Disease is a lifelong disabling disease, and also one of the most difficult digestive diseases to diagnose and treat abdominal pain diarrhea It will bring varying degrees of influence to the patient's body and psychology. We are committed to studying a safe, timely, effective and patient-centered health management model, and establishing a diagnosis and treatment team composed of professionals from multiple disciplines such as internal medicine, surgery, endoscopy, radiation, pathology, nursing, etc. to provide timely diagnosis and appropriate treatment for patients with inflammatory bowel disease, and complete the "admission", "filing" A series of appropriate services such as' follow-up 'and' education 'will help patients return to normal life as much as possible. "

   Inflammatory enteropathic The main treatment objectives are get Clinical remission( Asymptomatic Or mild symptoms) Stop glucocorticoid, quickly control symptoms and Reach stickiness Membrane healing( Restore intestinal function )。 Director of Shanghai Inflammatory Bowel Disease Research Center, Deputy Director of Shanghai Digestive Disease Research Institute Professor Ran Zhihua, deputy director of the Department of Gastroenterology of Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine, said, "China's Consensus on the Diagnosis and Treatment of Inflammatory Bowel Disease (2012) pointed out that patients with two or more high-risk factors should consider early active treatment when starting treatment, such as the use of biological agents and (or) immune agents. These high risk factors include: hormone is required for the first treatment; Young onset( <40 Age); Combined with perianal diseases; widely STD Change( >1m ); Lesions of esophagus, stomach and duodenum. Relevant research confirms [2] The mucosal healing rate can reach 50%~70% with biological agents, and 73% with early combined immunotherapy. Biological agents are superior to traditional drugs in both the rate of mucosal healing and the quality of mucosal healing. "

       Inflammatory bowel disease, such as Crohn's disease, has recently received more and more attention and support. Professor Qian said that at the beginning of this year, Zhejiang and Qingdao had included biological agents for Crohn's disease in local medical insurance coverage. It is believed that in the future, as more people gradually understand Crohn's disease and the patient groups suffering from disease, more assistance policies and projects will be introduced to benefit more patients in need of help.

       Ms. Zheng Lei, vice president of Xi'an Janssen Pharmaceutical Co., Ltd., said: "Xi'an Janssen has always paid attention to and cared for the group of patients with inflammatory bowel disease. In addition to providing advanced drugs and developing new products to meet the treatment needs of patients, it is also committed to arousing the public's awareness of this disease and the attention of patient groups through public disease publicity activities."

       It is reported that this year, "Love · Often in the "disease publicity campaign", the "online" will be the main battlefield, and HTML5 "love" will be launched · The "Chang Zai" map, the World Inflammatory Bowel Disease Day and Crohn's Disease Information Map, as well as Crohn's Disease story videos and other forms of disease publicity information.

Article keywords: World Inflammatory Bowel Disease Day Inflammatory enteropathy

Share to:
Collection   |   preservation   |   Print   |   close

Favorite!

You can use Sina's homepage (www.sina.com.cn) Top“ My Collection ”, view all the favorite articles.

got it

zero
Collection succeeded View my favorites
Guess you like it

Those who have read this article have also read